Top Back to top

Accreditation Fees 2019

The following fees were approved by the EBMT Board on 12 January, 2019. The new fees will be effective from Wednesday, 1 May, 2019. All applications received after 30 April will be subject to the new fees. See below for details.

For applications received before 1 May, 2019, please click here to see applicable fees.

Centres are reminded that a discount continues to be available for centres providing 1 or more active inspectors with 15% for one and 20% for 2 or more.

The fees increase is necessary to increase the JACIE office team providing support to inspectors and centres at a time when activity is growing due to increasing interest from centres in Low- to Middle-Income Countries and the arrival of immune effector cells such as CAR-T cell therapy in Europe and elsewhere.

Furthermore, fees income will support the EBMT clinical outcome benchmarking initiative which is being developed under the umbrella of the Project 2020 registry upgrade. The project is progressing well with a beta-version expected later in 2019 and a final mechanism in 2020 whereby centres reporting data to the EBMT registry will be able to generate a report comparing their outcome against the wider data-set in response to the requirements of the Standards. 

Inspection fees per area * full fees fees for ebmt members
1 Area €21,450 €10,725
2 Areas €26,796 €13,398
3 Areas €32,120 €16,060

Supplementary fee per additional Clinical, Collection, and/or Processing sites and for including administration of Immune Effector Cells within the scope of the accreditation+

€4,400 €2,200
Discount per active inspector €

15% - 1 active inspector
20% - > 1 active inspector

15% - 1 active inspector
20% - > 1 active inspector
* Areas

one (1) adult OR one (1) paediatric clinical site/unit
one (1) collection site for marrow #
one (1) for collection site for peripheral blood progenitor cells (apheresis)
one (1) cell-processing laboratory

$ Where an application includes a clinical unit that is a member of the EBMT, a 50% discount is applied to the Full Fees. For information on EBMT membership, please go to the Become a Member page. EBMT member centres should be up-to-date with their membership payments to the society at the time of application for accreditation.

Applications that do not include a clinical unit, e.g. Collection and Processing service, will be charged at the EBMT Member Fees rate.


  • Application with Clinical, Collection, Processing - Clinical Unit, not EBMT member = €32,120
  • Application with Clinical, Collection, Processing - Clinical Unit, is EBMT member = €16,060
  • Application with Clinical, Collection, Processing - Clinical Unit, administration of Immune Effector Cells, is EBMT member = €18,260
  • Application with Collection, Processing excluding Clinical Unit - €13,398
+ Supplementary Fee

Additional sites are considered to be where the application includes:

  • a clinical site transplanting both adult and paediatric patients
  • administration of Immune Effector Cells
  • more than one (1) adult inpatient clinical site
  • more than one (1) paediatric inpatient clinical site
  • more than one (1) peripheral blood collection site
  • more than one (1) bone marrow collection site
  • more than one (1) cell processing laboratory 
€ Discount scheme for Active Inspectors

Applications from centres whose staff members have participated in an inspection event(s) in the 4 years preceding submission of the new application will qualify for a discount of 15% per event. Where the centre has more than one active inspector, a maximum discount of 20% applies.
The discount scheme is designed to compensate centres that actively support the accreditation programme by releasing staff members to participate in inspections. This willingness to share the effort has been and remains one of the fundamental factors for sustaining the success of the JACIE programme. For further details, please consult the Accreditation Office.

Applications for accreditation of bone marrow collection will incur no charge when they form part of a simultaneous application for clinical accreditation. Where an application is received for bone marrow collection with no associated clinical inspection, or with an apheresis and/or processing unit, then a fee will be charged. 

Value Added Tax

JACIE is part of the EBMT which is a Netherlands-based foundation. For this reason, no Value Added Tax (VAT) is applied to applications from outside The Netherlands. The invoice refers to the reverse VAT arrangements within the EU and any tax responsibilities should be clarified with the relevant local authorities. See here for full details of EBMT's legal and fiscal registration.

Fee income is invested as follows:

  • Support development of outcome benchmarking mechanism to facilitate requirements under Standard B4.7.5
  • Increased support from central office - additional Accreditation Coordinator
  • Development of 'First-Step' certification scheme for centres in Low- to Middle-Income Economies (LMIEs)
  • Increased per diem payment to inspectors - inclusion of payment for travel day
  • Support Standards development - 8th edition preparation starts in 2019
  • Training and education
  • Process improvement

This is the fourth JACIE fee increase since 1 January, 2009. Since then inspections have increased from 23 in 2009 to 78 in 2018, with the associated need to expand the support team while also providing benefits for inspectors undertaking the inspections. The previous increase was in April 2017.

JACIE is run on a not-for-profit basis in line with the EBMT mission and values. JACIE relies almost exclusively on accreditation fees in order to support standard-setting and accreditation activities. The principal costs come from maintaining the small Accreditation Office team in Barcelona and Inspectors' travel, accommodation and subsistence expenses. Other activities include supporting the Standards review process, inspector training and systems support and development.